Cargando…

The Preclinical Research Progress of Stem Cells Therapy in Parkinson's Disease

Parkinson's disease (PD) is a type of degenerative disorder of the basal ganglia, causing tremor at rest, muscle rigidity hypokinesia, and dementia. The effectiveness of drug treatments gradually diminishes because the conversion to dopamine within the brain is increasingly disrupted by the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jun, Wang, Xianyun, Li, Jing, Huang, Rui, Yu, Xuerui, Dong, Ci, Liu, Pujuan, Zhang, Fan, Hu, Jie, Qi, Yixin, Zhang, Jing, Li, Quanhai, Yan, Baoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917676/
https://www.ncbi.nlm.nih.gov/pubmed/27379248
http://dx.doi.org/10.1155/2016/5683097
Descripción
Sumario:Parkinson's disease (PD) is a type of degenerative disorder of the basal ganglia, causing tremor at rest, muscle rigidity hypokinesia, and dementia. The effectiveness of drug treatments gradually diminishes because the conversion to dopamine within the brain is increasingly disrupted by the progressive degeneration of the dopaminergic terminals. After long-term treatment, most patients with PD suffer from disability that cannot be satisfactorily controlled. To solve these issues, stem cells have recently been used for cell therapy of PD. In this review, the characteristics of different stem cells and their therapeutic effects on PD treatment will be discussed.